News

Investor News from Reuters

December 22, 2009 - REUTERS

Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board

November 24, 2009 - REUTERS

Delcath Systems, Inc. Sponsors Satellite Session at World Meeting of Melanoma/Skin Cancer Centers

November 19, 2009 - REUTERS

Delcath Systems Reports Substantial Progress

November 16, 2009 - REUTERS

Delcath Systems to Present at Lazard Capital Markets 6th Annual Healthcare Conference

November 13, 2009 - REUTERS

Delcath Systems, Inc. Prices $30.6 Million Stock Offering

October 27, 2009 - REUTERS

Delcath Systems, Inc. Announces Public Offering of Common Stock

October 23, 2009 - REUTERS

Delcath Systems Completes Executive Management Team with Strategic New Hires

October 21, 2009 - REUTERS

Delcath Systems, Inc. Completes Phase III Study Enrollment

October 02, 2009 - REUTERS

Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer

September 14, 2009 - REUTERS

Delcath Systems, Inc. Appoints David McDonald Chief Financial Officer

September 11, 2009 - REUTERS

Data Safety Monitoring Board Unanimously Recommends Continuation of Delcath's Phase III Clinical Trial

September 04, 2009 - REUTERS

Delcath Systems, Inc. to Present Poster at International Liver Cancer Association 2009 Annual Conference

September 04, 2009 - REUTERS

Delcath Systems to Present at Renshaw 11th Annual Healthcare Conference

September 03, 2009 - REUTERS

Delcath Establishes Queensbury, NY Operations Facility

August 31, 2009 - REUTERS

FDA Grants Delcath Orphan-Drug Designation for Doxorubicin

August 25, 2009 - REUTERS

Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90%

August 10, 2009 - REUTERS

Delcath Systems to Present at Canaccord Adams 29th Annual Global Growth Conference

July 27, 2009 - REUTERS

Delcath Systems Provides Update on Progress

July 14, 2009 - REUTERS

Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress

July 06, 2009 - REUTERS

Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.

June 15, 2009 - REUTERS

Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index

June 10, 2009 - REUTERS

Delcath Enters Agreement to Sell 869,565 Units

June 08, 2009 - REUTERS

Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual

June 02, 2009 - REUTERS

Delcath Systems Granted Third Orphan Drug Designation

May 07, 2009 - REUTERS

Eric D. Whitman, MD to Present on the Delcath PHP Systemâ„¢ at the 7th World Congress on Melanoma

April 15, 2009 - REUTERS

Delcath Systems to Host Quarterly Update Conference Call

April 09, 2009 - REUTERS

Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)

March 23, 2009 - REUTERS

DATA SAFETY MONITORING BOARD UNANIMOUSLY RECOMMENDS CONTINUATION OF DELCATH PHASE III CLINICAL TRIAL FOR INOPERABLE METASTATIC MELANOMA

February 19, 2009 - REUTERS

Dr. James F. Pingpank to Present at Leading Regional Therapies Conference

January 20, 2009 - REUTERS

Delcath Systems to Host Quarterly Update Conference Call